Quick Answer
KESTRA MEDICAL TECHNOLOGIES, LTD. reported Revenue (ASC 606) of $59.81 million for fiscal year 2025.
KESTRA MEDICAL TECHNOLOGIES, LTD. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $59.81M | +115.1% |
| 2024 | $27.81M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $24.55M | +62.7% | +8.8% |
| October 31, 2025 | $22.57M | +53.4% | +16.5% |
| July 31, 2025 | $19.37M | +51.5% | +28.4% |
| January 31, 2025 | $15.09M | — | +2.6% |
| October 31, 2024 | $14.71M | — | +15.1% |
| July 31, 2024 | $12.78M | — | — |
- KESTRA MEDICAL TECHNOLOGIES, LTD. showed an increase of +115.1% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2024–2025 period, KESTRA MEDICAL TECHNOLOGIES, LTD.’s revenue (asc 606) has grown by 115.1% (from $27.81 million to $59.81 million).
- The most recent figure is from KESTRA MEDICAL TECHNOLOGIES, LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: